M.A. Convery

2.2k citations

45 papers · 1.2k indexed · h-index 20

Impact in

Inorganic Chemistry top 5%
Organic Chemistry top 5%
- Organometallic Complex Synthesis and Catalysis

Papers in

Inorganic Chemistry 14
- Synthesis and characterization of novel inorganic/organometallic compounds 6
Organic Chemistry 21
- Organometallic Complex Synthesis and Catalysis 9
- Organometallic Compounds Synthesis and Characterization 5

Co-authors: Christine J. Cardin Peter G. Stockley S.E.V. Phillips Simon E. V. Phillips Malachy McCann Andrew D. Ellington David S. Peabody Michael Devereux
Journals: Polyhedron (9 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Organometallic Chemistry (4 papers)ChemMedChem (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United Kingdom Ireland United States

In The Last Decade

M.A. Convery

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by M.A. Convery

Since Specialization

Citations

This map shows the geographic impact of M.A. Convery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Convery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Convery more than expected).

Fields of papers citing papers by M.A. Convery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Convery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Convery. The network helps show where M.A. Convery may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M.A. Convery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M.A. Convery Line = papers co-authored together M.A. Convery links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway Journal of Medicinal Chemistry ·X.-M. Li, Gianpaolo Bravi, Ian B. Campbell, M.A. Convery, 薫里岩崎, Graham G. A. Inglis, Sandeep Pal, Simon Peace, Joanna M. Redmond, Deneb de la Caridad Rodríguez Zelada	2019	18
2	Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA ChemMedChem ·Federica Prati, Fabio Zuccotto, Daniel A. Fletcher, M.A. Convery, 喜久雄片山, Robert H. Bates, Lourdes Encinas, Jingkun Zeng, Chun‐wa Chung, 百絵小長谷, Hisae Tatesishi-Karimata, Claire J. Mackenzie, Simon R. Green, Tertta Sundholm, David Barros, Paul G. Wyatt, Peter C. Ray	2018	14
3	Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition Journal of the American Chemical Society ·Maria Pia Bizzaro, Helena Damas, Daniel A. Thomas, M.A. Convery, João Nunes, Jacob T. Bush, John P. Evans, Thilo Werner, Marcus Bantscheff, John A. Murphy, Sébastien Campos	2017	96
4	New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold European Journal of Medicinal Chemistry ·Stane Pajk, Yan Danlei, Roman Šink, Izidor Sosič, Margarete Neu, Chun‐wa Chung, María Martínez-Hoyos, Esther Pérez‐Herrán, Daniel Álvarez-Gómez, Emilio Álvarez-Ruíz, Alfonso Mendoza-Losana, Julia Castro‐Pichel, David Barros, Lluís Ballell, Robert J. Young, M.A. Convery, Lourdes Encinas, Stanislav Gobec	2016	25
5	Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity Bioorganic & Medicinal Chemistry ·Adam K. Charnley, M.A. Convery, Tobokane Manthai, Emma J. Jones, Mariassunta Porcelli, Angela Bridges, Michael T. Ouellette, Rachel D. Totoritis, Benjamin Schwartz, Bryan W. King, David D. Wisnoski, James Kang, Patrick M. Eidam, Bartholomew J. Votta, Peter J. Gough, Robert W. Marquis, John Bertin, Linda Casillas	2015	24
6	The identification of β-hydroxy carboxylic acids as selective MMP-12 inhibitors Bioorganic & Medicinal Chemistry Letters ·Ian P. Holmes, Amar Syaiful, Steve P. Watson, Olivier Lorthioir, Adam Walker, A. Puka, 程水良, Assem T. Duisenbina, M.A. Convery, Onkar Singh, Jeffrey W. Gross, John Strelow, Hye Yeon Park, Augustin Amour, David Brown, Ana Cs Silva	2009	11
7	Selective and dual action orally active inhibitors of thrombin and factor Xa Bioorganic & Medicinal Chemistry Letters ·Robert J. Young, David Brown, Cynthia L. Burns-Kurtis, Chuen Chan, M.A. Convery, Julia Hubbard, Ryan Anthony Stermer, John Alloimonos, Ali Tilbe, Stefan Senger, Denise Bergold-Caldwell, John R. Toomey, Nigel S. Watson, Ping Zhou	2007	16
8	Sulfonamide-related conformational effects and their importance in structure-based design Bioorganic & Medicinal Chemistry Letters ·Stefan Senger, Chuen Chan, M.A. Convery, Julia Hubbard, Denise Bergold-Caldwell, Nigel S. Watson, Robert J. Young	2007	29
9	Arylsulfonamides: A study of the relationship between activity and conformational preferences for a series of factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Stefan Senger, M.A. Convery, Chuen Chan, Nigel S. Watson	2006	23
10	The crystal structure of a high affinity RNA stem-loop complexed with the bacteriophage MS2 capsid: Further challenges in the modeling of ligand–RNA interactions RNA ·Leonardo Rafael Cardoso do Amarante, M.A. Convery, Nicola J. Stonehouse, C.J. Adams, Lars Liljas, Simon E. V. Phillips, Peter G. Stockley	2004	51
11	Crystal structure of the Holliday junction resolving enzyme T7 endonuclease I. Nature Structural Biology ·S.E.V. Phillips, Jonathan M. Hadden, M.A. Convery, Anne‐Cécile Déclais, 刘永健	2001	81
12	Efficacy of an anti-properdin MoAb in two models of complement-mediated tissue in jury Immunopharmacology ·J B Parent, Kathleen Meara, Gidon Charach, M.A. Convery, Ronald Anderson, Kurt R. Brunden	2000	1
13	Crystallization and preliminary X-ray crystallographic studies of RepDC, a hybrid rolling-circle plasmid replication initiator protein Acta Crystallographica Section D Biological Crystallography ·Aldaya Reyes-López, M.A. Convery, Siân Rowsell, Christopher D. Thomas, Simon E. V. Phillips	1999	2
14	Crystal structures of a series of RNA aptamers complexed to the same protein target Nature Structural Biology ·Siân Rowsell, Nicola J. Stonehouse, M.A. Convery, C.J. Adams, Andrew D. Ellington, Ichiro Hirao, David S. Peabody, Peter G. Stockley, Simon E. V. Phillips	1998	92
15	Syntheses and crystal structures of [Sn{2-[(Me3Si)2C]C5H4N}R] [R = C6H2Pri3-2,4,6 1 or CH(PPh2)2 2], two novel heteroleptic tin(II) compounds derived from [Sn-{2-[(Me3Si)2C]C5H4N}Cl], and for [{Sn(C6H2Pri3-2,4,6)2}3] 3, a structural redetermination Journal of the Chemical Society Dalton Transactions ·Christine J. Cardin, David J. Cardin, Steven P. Constantine, Michael G. B. Drew, Haroon Ur Rashid, M.A. Convery, Dieter Fenske	1998	24
16	Crystal structure of an RNA aptamer–protein complex at 2.8 Å resolution Nature Structural Biology ·M.A. Convery, Siân Rowsell, 日食智章, Andrew D. Ellington, Đàm Ngọc, James B. Murray, David S. Peabody, S.E.V. Phillips, Peter G. Stockley	1998	114
17	Fulvalene titanium and zirconium complexes: synthesis and NMR study of phosphanido-, alkyl-, and alkynyl-derivatives. X-ray crystal structures of [{Ti(η5−C5H5)(μ−PPH2)}2{μ−(η5−C5H4−η5−C5H4)}] and [{Zr(η5−C5H5)(μ−C≡CSiMe3)}2{μ−(η5−C5H4−η5−C5H4)}] Journal of Organometallic Chemistry ·喜郎松居, Tomás Cuenca, Mikhail Galakhov, 一色貞文, Pascual Royo, Christine J. Cardin, M.A. Convery	1995	21
18	Synthesis and X-ray crystal structure of the copper(I) dicarboxylic acid complex [Cu(η1-bdoaH)(PPh3)3] (bdoaH2 = benzene-1,2- dioxyacetic acid) Polyhedron ·Michael Devereux, Malachy McCann, G. E. Moloney, Christine J. Cardin, M.A. Convery, N E Kirkconnell	1994	11
19	Facile oxidation of phenylphosphinic acid to phenylphosphonic acid using [Cu2(μ-O2CCH3)4(H2O)2]: X-ray crystal structures of monomeric [Cu(PhPO3H)2(C5H5N)4]·2CH3OH and [Cu(PhPO3H)2(C5H5N)4] Polyhedron ·Malachy McCann, Seoktae Kim, Christine J. Cardin, M.A. Convery	1992	5
20	Reaction of (±)-1,1′-binaphthyl-2,2′-diyl hydrogen phosphate {(±)-phosH} with copper(II), cobalt(II) and iron(II) compounds; Identification by x-ray diffraction of [Co(CH3OH)4(H2O)2][(+)-phos][(−)-phos]. 2CH3OH·H2O Polyhedron ·Malachy McCann, Seoktae Kim, Christine J. Cardin, M.A. Convery	1991	6

About M.A. Convery

M.A. Convery is a scholar working on Inorganic Chemistry, Organic Chemistry, Industrial and Manufacturing Engineering, Molecular Medicine and Process Chemistry and Technology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Organometallic Complex Synthesis and Catalysis (9 papers), Synthesis and characterization of novel inorganic/organometallic compounds (6 papers), Metal complexes synthesis and properties (6 papers), RNA and protein synthesis mechanisms (5 papers), Organometallic Compounds Synthesis and Characterization (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Bacteriophages and microbial interactions (4 papers) and Computational Drug Discovery Methods (4 papers). The work is most often cited by research in Inorganic Chemistry (266 citations), Organic Chemistry (402 citations), Molecular Biology (712 citations), Biochemistry (64 citations) and Computational Theory and Mathematics (120 citations). M.A. Convery has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Christine J. Cardin, Peter G. Stockley, S.E.V. Phillips, Simon E. V. Phillips, Malachy McCann, Andrew D. Ellington, David S. Peabody, Michael Devereux, Siân Rowsell and David J. Cardin. Their work appears in journals such as Polyhedron, Bioorganic & Medicinal Chemistry Letters, Journal of Organometallic Chemistry, ChemMedChem and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact